Results 261 to 270 of about 522,034 (344)
Angiogenic Ability of Extracellular Vesicles Derived from Angio-miRNA-Modified Mesenchymal Stromal Cells. [PDF]
Wada Y +7 more
europepmc +1 more source
Studies of Spinal Motor Control Networks in Genetically Modified Mouse Models
Henrik Gezelius
openalex +1 more source
Generation of genetically modified mouse models to study rare genetic diseases
openaire +1 more source
The lipid droplet inhibitor (LDI), templated with large‐pore mesoporous silica and functionalized with PKCα C1A and lipase, targets lipid degradation in fatty liver. The LDI maintains stable association with lipid droplets, thereby suppressing their formation and expansion.
Seunghee Kim +12 more
wiley +1 more source
Engineered macrophages accumulate in solid tumors and locally deliver immune-activating proteins to inhibit tumor progression. [PDF]
Xu Y, Zhou Y, Wang J.
europepmc +1 more source
Rapid Fabrication of Self‐Propelled and Steerable Magnetic Microcatheters for Precision Medicine
A rapid Joule heating fabrication method for the production of self‐propelling, adaptive microcatheters, with tunable stiffness and integrated microfluidic channels is presented. Demonstrated through three microrobotic designs, including a steerable guiding catheter, an untethered wave‐crawling TubeBot, and a distal‐end propelled microcatheter, it was ...
Zhi Chen +5 more
wiley +1 more source
Bacteria in neoplastic diseases: A brief note on Wilms tumor. [PDF]
Burke A, Sanyaolu A, Ray A.
europepmc +1 more source
MXene and MBene nanomaterials show significant potential in addressing critical challenges in biomedicine, applied biology, agriculture, and the environment. From a nano‐agricultural perspective, this relatively young field has witnessed emerging advances towards applications for plant‐immunoengineering, biostimulation, and controlled delivery ...
Alireza Rafieerad +3 more
wiley +1 more source
Engineering hypoimmune stem cell-derived beta cells. [PDF]
Licht BJM, Duffy GP, Levey RE.
europepmc +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source

